Germany: Sang-Jin Pak to replace Michael Schönhofen as head of Biopharma business at Fresenius Kabi

After more than 30 years, Dr Michael Schönhofen, head of the Biopharma business on the Fresenius Kabi management board, will leave the company on June 30, 2024. His responsibilities will […]